8 hours Novo Nordisk Slips On Analyst Warning Of Weaker Wegovy Sales Investor's Business Daily
Novo Nordisk stock fell after a JPMorgan analyst said sales of its blockbuster weight-loss drug may be weaker-than-expected.
The post Novo Nordisk Slips On Analyst Warning Of Weaker Wegovy Sales appeared first on Investor's Business Daily.